| |
|
|
|
Matinas BioPharma Holdings Inc.  
|
|
0.8983 -0.162 (-0.15%) |
10-19 16:00 |
|
Open: |
1 |
Pre close: |
1.06 |
Target:
|
1.25 
|
|
High: |
1.02 |
Low: |
0.88 |
Resistance:
|
1.07
1.48
|
|
Volume: |
4,130,648 |
Market Cap: |
85M |
Support:
|
0.40
0.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.88
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
0.84 |
Signal(12,26,9): |
0.09 |
|
MA(100): |
0.52 |
Stochastic Oscillator |
%K(14,3):
|
29.25 |
|
MA(250): |
0.81 |
%D(3): |
25.03 |
|
Average Volume(K) |
3-Month: |
180221
|
52-Week |
High:
|
1.60 |
|
10-Days: |
462616 |
Low: |
0.32 |
|
RSI |
RSI(14):
|
57.90 |
Change(%): |
-21.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-315.0 |
Shares Out. (M) |
94.64 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-88.5 |
Shares Float (M) |
81.54 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
100.0 |
% Held by Institutions |
8.90 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2101 |
|
Book Value (p.s.) |
11.750 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.08 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.76 |
P/S |
0.00 |
|
Operating Margin |
-7236.31 |
Levered Free Cash Flow
(M) |
-5.36 |
P/CF |
-8.71 |
|
|
|
|
|
|
